Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-24 @ 8:03 PM
NCT ID:
NCT05955404
Eligibility Criteria:
Inclusion Criteria:
* Preterm infants whose corrected gestational age from (32 - \<37) weeks of pregnancy
* Preterm infants who do not experience any painful procedure for last 24 hours
* Preterm infants do not receive any sedation for last 24 hours
Exclusion Criteria:
* full-term infants whose corrected gestational age is \>37 weeks
* extremely preterm (\< 28 weeks)
* very preterm (28-\<32 weeks)
* proven or suspected sepsis
* major congenital malformations
* all heart defect except neonatal Patent ductus arteriosus (PDA)
* necrotizing enterocolitis
* neurodevelopmental disability
* who receive respiratory support {Mechanical Ventilation, Continuous Positive Airway Pressure, or high-flow support
* indicated for surgery
* contraindication to oral sucrose
* Twins
* infants had a condition that might influence their responses to pain, e.g., congenital anomalies or severe illnesses requiring treatment with antiepileptics, muscle relaxants, or analgesic drugs
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
32 Weeks
Maximum Age:
37 Weeks
Study:
NCT05955404
Study Brief:
Protocol Section:
NCT05955404